Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Radiosurgery"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 21-40 z 27727
Tytuł:
Efficacy and indications of gamma knife radiosurgery for recurrent low-and high-grade glioma.
Autorzy:
Sun Y; Department of Radiation Oncology, General Hospital of Northern Theater Command, 110016, Shenyang, China.
Liu P; Beifang Hospital of China Medical University, 110016, Shenyang, China.
Wang Z; Graduate School of Dalian Medical University, 116000, Dalian, China.
Zhang H; Department of Radiation Oncology, General Hospital of Northern Theater Command, 110016, Shenyang, China.
Xu Y; Department of Radiation Oncology, General Hospital of Northern Theater Command, 110016, Shenyang, China.
Hu S; Department of Radiation Oncology, General Hospital of Northern Theater Command, 110016, Shenyang, China.
Yan Y; Department of Radiation Oncology, General Hospital of Northern Theater Command, 110016, Shenyang, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jan 05; Vol. 24 (1), pp. 37. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:
Journal Article
MeSH Terms:
Radiosurgery*/adverse effects
Glioma*/radiotherapy
Glioma*/surgery
Humans ; Retrospective Studies ; Brain ; Brain Stem
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Robotic stereotactic radiosurgery with CyberKnife - brain metastases and fibrinolysis.
Autorzy:
Popov V
Graklanov V
Stoencheva S
Grudeva-Popova Z
Pokaż więcej
Źródło:
Bratislavske lekarske listy [Bratisl Lek Listy] 2024; Vol. 125 (3), pp. 149-152.
Typ publikacji:
Journal Article
MeSH Terms:
Radiosurgery*
Robotic Surgical Procedures*
Brain Neoplasms*/radiotherapy
Humans ; Urokinase-Type Plasminogen Activator/analysis ; Fibrinolysis ; Longitudinal Studies ; Prospective Studies ; Neoplasm Recurrence, Local ; Plasminogen Activator Inhibitor 1/analysis ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Stereotactic radiosurgery of brain metastases: a retrospective study.
Autorzy:
Gruber I; Department of Radiation Oncology, University Hospital Regensburg, Franz-Josef-Strauss Allee 11, Regensburg, Bavarian, 93053, Germany. .
Weidner K; Department of Radiation Oncology, University Hospital Regensburg, Franz-Josef-Strauss Allee 11, Regensburg, Bavarian, 93053, Germany.
Treutwein M; Department of Radiation Oncology, University Hospital Regensburg, Franz-Josef-Strauss Allee 11, Regensburg, Bavarian, 93053, Germany.
Koelbl O; Department of Radiation Oncology, University Hospital Regensburg, Franz-Josef-Strauss Allee 11, Regensburg, Bavarian, 93053, Germany.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2023 Dec 19; Vol. 18 (1), pp. 202. Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:
Journal Article
MeSH Terms:
Radiosurgery*/methods
Melanoma*/radiotherapy
Melanoma*/surgery
Melanoma*/secondary
Brain Neoplasms*/radiotherapy
Brain Neoplasms*/surgery
Brain Neoplasms*/pathology
Kidney Neoplasms*/surgery
Carcinoma, Renal Cell*
Sarcoma*/surgery
Humans ; Retrospective Studies ; Necrosis/etiology ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Concomitant radiosurgical and targeted oncological treatment improves the outcome of patients with brain metastases from gastrointestinal cancer.
Autorzy:
Khalaveh F; Department of Neurosurgery, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Cho A; Department of Neurosurgery, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Shaltout A; Department of Neurosurgery, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Untersteiner H; Department of Neurosurgery, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.; Department of Neurology, Medical University of Vienna, Vienna, Austria.
Kranawetter B; Department of Neurosurgery, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Hirschmann D; Department of Neurosurgery, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Göbl P; Department of Neurosurgery, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Marik W; Department of Radiology, Division of Neuro- and Musculoskeletal Radiology, Medical University of Vienna, Vienna, Austria.
Gatterbauer B; Department of Neurosurgery, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Rössler K; Department of Neurosurgery, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Dorfer C; Department of Neurosurgery, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Frischer JM; Department of Neurosurgery, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2023 Dec 09; Vol. 18 (1), pp. 197. Date of Electronic Publication: 2023 Dec 09.
Typ publikacji:
Journal Article
MeSH Terms:
Radiosurgery*/adverse effects
Brain Neoplasms*/secondary
Gastrointestinal Neoplasms*
Radiation Injuries*/etiology
Humans ; Retrospective Studies ; Karnofsky Performance Status ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Dose escalation for stereotactic arrhythmia radioablation of recurrent ventricular tachyarrhythmia - a phase II clinical trial.
Autorzy:
Kovacs B; Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland.; Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor, USA.; Center for Translational and Experimental Cardiology (CTEC), University of Zurich, Zurich, Switzerland.
Mayinger M; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
Ehrbar S; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
Fesslmeier D; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
Ahmadsei M; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
Sazgary L; Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland.; Center for Translational and Experimental Cardiology (CTEC), University of Zurich, Zurich, Switzerland.
Manka R; Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland.; Center for Translational and Experimental Cardiology (CTEC), University of Zurich, Zurich, Switzerland.; Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
Alkadhi H; Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
Ruschitzka F; Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland.; Center for Translational and Experimental Cardiology (CTEC), University of Zurich, Zurich, Switzerland.; Center for Integrative Human Physiology, University Zurich, Zurich, Switzerland.
Duru F; Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland.; Center for Translational and Experimental Cardiology (CTEC), University of Zurich, Zurich, Switzerland.; Center for Integrative Human Physiology, University Zurich, Zurich, Switzerland.
Papachristofilou A; Department of Radiation Oncology, University Hospital Basel, Basel, Switzerland.
Sticherling C; Department of Cardiology, University Hospital Basel, Basel, Switzerland.
Blamek S; Department of Radiotherapy, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice, Poland.
Gołba KS; Department of Electrocardiology, Upper Silesian Heart Center, Medical University of Silesia, Katowice, Poland.; Department of Electrocardiology and Heart Failure, Medical University of Silesia, Katowice, Poland.
Guckenberger M; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
Saguner AM; Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland.; Center for Translational and Experimental Cardiology (CTEC), University of Zurich, Zurich, Switzerland.; Center for Integrative Human Physiology, University Zurich, Zurich, Switzerland.
Andratschke N; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2023 Nov 08; Vol. 18 (1), pp. 185. Date of Electronic Publication: 2023 Nov 08.
Typ publikacji:
Clinical Trial, Phase II; Multicenter Study; Journal Article
MeSH Terms:
Radiosurgery*/adverse effects
Radiosurgery*/methods
Tachycardia, Ventricular*/radiotherapy
Tachycardia, Ventricular*/surgery
Tachycardia, Ventricular*/etiology
Humans ; Prospective Studies ; Cicatrix/etiology ; Cicatrix/surgery ; Heart
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Treating brain metastases in metastatic breast cancer: outcomes after stereotactic radiosurgery examined in a retrospective, single-center cohort analysis.
Autorzy:
Depner JF; Danish Breast Cancer Cooperative Group, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Berg T; Danish Breast Cancer Cooperative Group, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Oncology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Ejlertsen B; Danish Breast Cancer Cooperative Group, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Oncology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Andreasen LW; Department of Clinical Oncology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Møller S; Department of Clinical Oncology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Maraldo MV; Department of Clinical Oncology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Nov; Vol. 62 (11), pp. 1502-1510. Date of Electronic Publication: 2023 Nov 07.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Radiosurgery*/methods
Brain Neoplasms*/secondary
Humans ; Female ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Dynamic functional changes upon thalamotomy in essential tremor depend on baseline brain morphometry.
Autorzy:
Bolton TAW; Department of Clinical Neurosciences, Neurosurgery Service and Gamma Knife Center, Centre Hospitalier Universitaire Vaudois, 1011, Lausanne, Switzerland. .; Department of Radiology, Lausanne University Hospital and University of Lausanne (CHUV-UNIL), 1011, Lausanne, Switzerland. .
Van De Ville D; Neuro-X Institute, Ecole Polytechnique Fédérale de Lausanne, 1202, Geneva, Switzerland.; Department of Radiology and Medical Informatics, University of Geneva, 1202, Geneva, Switzerland.
Régis J; Stereotactic and Functional Neurosurgery Service and Gamma Knife Unit, Assistance Publique-Hôpitaux de Marseille, Centre Hospitalier Universitaire de la Timone, 13005, Marseille, France.
Witjas T; Neurology Department, Assistance Publique-Hôpitaux de Marseille, Centre Hospitalier Universitaire de la Timone, 13005, Marseille, France.
Girard N; Department of Diagnostic and Interventional Neuroradiology, Centre de Résonance Magnétique Biologique et Médicale, Assistance Publique-Hôpitaux de Marseille, Centre Hospitalier Universitaire de la Timone, 13005, Marseille, France.
Levivier M; Department of Clinical Neurosciences, Neurosurgery Service and Gamma Knife Center, Centre Hospitalier Universitaire Vaudois, 1011, Lausanne, Switzerland.; Faculty of Biology and Medicine (FBM), University of Lausanne (UNIL), 1015, Lausanne, Switzerland.
Tuleasca C; Department of Clinical Neurosciences, Neurosurgery Service and Gamma Knife Center, Centre Hospitalier Universitaire Vaudois, 1011, Lausanne, Switzerland.; Faculty of Biology and Medicine (FBM), University of Lausanne (UNIL), 1015, Lausanne, Switzerland.; Signal Processing Laboratory (LTS 5), Ecole Polytechnique Fédérale de Lausanne, 1015, Lausanne, Switzerland.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 31; Vol. 14 (1), pp. 2605. Date of Electronic Publication: 2024 Jan 31.
Typ publikacji:
Journal Article
MeSH Terms:
Essential Tremor*/diagnostic imaging
Essential Tremor*/surgery
Radiosurgery*/methods
Humans ; Magnetic Resonance Imaging/methods ; Treatment Outcome ; Thalamus/diagnostic imaging ; Thalamus/surgery ; Brain
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A PET/CT radiomics model for predicting distant metastasis in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy: a multicentric study.
Autorzy:
Yu L; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Zhang Z; Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands.
Yi H; Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.
Wang J; Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.
Li J; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Wang X; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Bai H; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Ge H; The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Zheng X; The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Ni J; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Qi H; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Science, Jinan, Shandong, China.
Guan Y; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Xu W; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Zhu Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Xing L; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Science, Jinan, Shandong, China.
Dekker A; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands.
Wee L; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands.
Traverso A; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands.
Ye Z; Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China. .
Yuan Z; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2024 Jan 22; Vol. 19 (1), pp. 10. Date of Electronic Publication: 2024 Jan 22.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Radiosurgery*
Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Carcinoma, Non-Small-Cell Lung*/surgery
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/surgery
Small Cell Lung Carcinoma*
Humans ; Positron Emission Tomography Computed Tomography ; Radiomics ; China ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Stereotactic body radiotherapy for early-stage lung cancer: a systematic review on the choice of photon energy and linac flattened/unflattened beams.
Autorzy:
Gill A; School of Physics, Mathematics and Computing, The University of Western Australia, Crawley, WA, 6009, Australia. .
Hirst AL; Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, 6009, Australia.
Rowshanfarzad P; School of Physics, Mathematics and Computing, The University of Western Australia, Crawley, WA, 6009, Australia.
Gill S; School of Physics, Mathematics and Computing, The University of Western Australia, Crawley, WA, 6009, Australia.; Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, 6009, Australia.
Bucknell N; Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, 6009, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, 3000, Australia.
Dass J; Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, 6009, Australia.
Sabet M; School of Physics, Mathematics and Computing, The University of Western Australia, Crawley, WA, 6009, Australia.; Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, 6009, Australia.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2024 Jan 02; Vol. 19 (1), pp. 1. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Radiosurgery*/methods
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Carcinoma, Non-Small-Cell Lung*/surgery
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/surgery
Lung Neoplasms*/pathology
Radiotherapy, Intensity-Modulated*/methods
Small Cell Lung Carcinoma*/surgery
Humans ; Radiotherapy Planning, Computer-Assisted/methods ; Lung/pathology ; Radiotherapy Dosage
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN study.
Autorzy:
Volpe S; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, 20141, Italy. .; Department of Oncology and Hemato-Oncology, University of Milan, Milan, 20122, Italy. .
Zaffaroni M; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, 20141, Italy. .
Piperno G; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, 20141, Italy.
Vincini MG; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, 20141, Italy.
Zerella MA; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, 20141, Italy.
Mastroleo F; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, 20141, Italy.; Department of Translational Medicine, University of Piemonte Orientale (UPO), Novara, 28100, Italy.
Cattani F; Unit of Medical Physics, European Institute of Oncology (IEO) IRCCS, Milan, 20141, Italy.
Fodor CI; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, 20141, Italy.
Bellerba F; Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, 20139, Italy.
Bonaldi T; Department of Oncology and Hemato-Oncology, University of Milan, Milan, 20122, Italy.; Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, 20139, Italy.
Bonizzi G; Biobank for Translational and Digital Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Ceci F; Department of Oncology and Hemato-Oncology, University of Milan, Milan, 20122, Italy.; Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, Milan, 20141, Italy.
Cremonesi M; Unit of Radiation Research, IEO European Institute of Oncology, IRCCS, Milan, Italy.
Fusco N; Department of Oncology and Hemato-Oncology, University of Milan, Milan, 20122, Italy.; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Gandini S; Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, 20139, Italy.
Garibaldi C; Unit of Radiation Research, IEO European Institute of Oncology, IRCCS, Milan, Italy.
Torre D; Department of Oncology and Hemato-Oncology, University of Milan, Milan, 20122, Italy.; SKEMA Business School, Université Côte d'Azur, Sophia Antipolis, France.
Noberini R; Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, 20139, Italy.
Petralia G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, 20122, Italy.; Precision Imaging and Research Unit, Department of Medical Imaging and Radiation Sciences, IEO European Institute of Oncology IRCCS, Milan, Italy.
Spaggiari L; Department of Oncology and Hemato-Oncology, University of Milan, Milan, 20122, Italy.; Division of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Milan, 20141, Italy.
Venetis K; Unit of Radiation Research, IEO European Institute of Oncology, IRCCS, Milan, Italy.
Orecchia R; Scientific Directorate, IEO European Institute of Oncology IRCCS, Milan, 20141, Italy.
Casiraghi M; Department of Oncology and Hemato-Oncology, University of Milan, Milan, 20122, Italy.; Division of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Milan, 20141, Italy.
Jereczek-Fossa BA; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, 20122, Italy.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Dec 15; Vol. 23 (1), pp. 1236. Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/genetics
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/pathology
Radiosurgery*/methods
Small Cell Lung Carcinoma*
Humans ; Multiomics ; Neoplasm Staging ; Observational Studies as Topic ; Proteomics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Histopathologically confirmed radiation-induced damage of the brain - an in-depth analysis of radiation parameters and spatio-temporal occurrence.
Autorzy:
Kossmann MRP; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Augustenburger Platz 1, 13353, Berlin, Germany.; Department of Radiotherapy and Radiation Oncology, Pius-Hospital Oldenburg, Georgstr. 12, 26121, Oldenburg, Germany.
Ehret F; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Augustenburger Platz 1, 13353, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Roohani S; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Augustenburger Platz 1, 13353, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Winter SF; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
Ghadjar P; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Augustenburger Platz 1, 13353, Berlin, Germany.
Acker G; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Augustenburger Platz 1, 13353, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurosurgery, Charitéplatz 1, 10117, Berlin, Germany.
Senger C; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Augustenburger Platz 1, 13353, Berlin, Germany.
Schmid S; Charité - Universitätsmedizin Berlin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Charitéplatz 1, 10117, Berlin, Germany.
Zips D; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Augustenburger Platz 1, 13353, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Kaul D; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Augustenburger Platz 1, 13353, Berlin, Germany. .; Charité - Universitätsmedizin Berlin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2023 Dec 12; Vol. 18 (1), pp. 198. Date of Electronic Publication: 2023 Dec 12.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/secondary
Glioma*/radiotherapy
Glioma*/pathology
Radiosurgery*/methods
Humans ; Brain/pathology ; Biopsy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Incorporating Stereotactic Ablative Radiotherapy into the Multidisciplinary Management of Renal Cell Carcinoma.
Autorzy:
Raj RK; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
Upadhyay R; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
Wang SJ; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
Singer EA; Division of Urologic Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
Dason S; Division of Urologic Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Dec 01; Vol. 30 (12), pp. 10283-10298. Date of Electronic Publication: 2023 Dec 01.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Renal Cell*/radiotherapy
Carcinoma, Renal Cell*/surgery
Radiosurgery*
Kidney Neoplasms*/surgery
Kidney Neoplasms*/pathology
Humans ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Short report: Plasma based biomarkers detect radiation induced brain injury in cancer patients treated for brain metastasis: A pilot study.
Autorzy:
Makranz C; Department of Neurology and Oncology, The Gaffin Center for Neurooncology, Sharett Institute for Oncology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Lubotzky A; Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, the Hebrew University-Hadassah Medical School, Jerusalem, Israel.; Division of Neurology and Department of Molecular Genetics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Zemmour H; Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, the Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Shemer R; Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, the Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Glaser B; Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, the Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Cohen J; Department of Oncology, Sharett Institute for Oncology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.; The Wohl Institute for Translational Medicine, Hadassah Medical Center, Jerusalem, Israel.
Maoz M; Department of Oncology, Sharett Institute for Oncology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Sapir E; Department of Radiation Oncology, Sharett Institute for Oncology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.; Radiation Oncology Institute, Samson Assuta Ashdod University Hospital, Ben Gurion University, Ashdod, Israel.
Wygoda M; Department of Radiation Oncology, Sharett Institute for Oncology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Peretz T; Department of Oncology, Sharett Institute for Oncology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Weizman N; Department of Radiation Oncology, Sharett Institute for Oncology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Feldman J; Department of Radiation Oncology, Sharett Institute for Oncology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Abrams RA; Department of Radiation Oncology, Sharett Institute for Oncology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Lossos A; Department of Neurology and Oncology, The Gaffin Center for Neurooncology, Sharett Institute for Oncology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Dor Y; Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, the Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Zick A; Department of Oncology, Sharett Institute for Oncology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Nov 28; Vol. 18 (11), pp. e0285646. Date of Electronic Publication: 2023 Nov 28 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/secondary
Brain Injuries*/etiology
Brain Injuries*/surgery
Radiosurgery*
Radiation Injuries*/etiology
Humans ; Pilot Projects ; Brain
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Predicting stereotactic radiosurgery outcomes with multi-observer qualitative appearance labelling versus MRI radiomics.
Autorzy:
DeVries DA; Department of Medical Biophysics, Western University, London, N6A 3K7, Canada. .; Gerald C. Baines Centre, London Health Sciences Centre, London, N6A 5W9, Canada. .
Tang T; Department of Radiation Oncology, London Health Sciences Centre, London, N6A 5W9, Canada.
Albweady A; Department of Radiology, Unaizah College of Medicine and Medical Sciences, Qassim University, 56219, Buraidah, Saudi Arabia.
Leung A; Department of Medical Imaging, Western University, London, N6A 3K7, Canada.
Laba J; Department of Radiation Oncology, London Health Sciences Centre, London, N6A 5W9, Canada.; Department of Oncology, Western University, London, N6A 3K7, Canada.
Johnson C; Gerald C. Baines Centre, London Health Sciences Centre, London, N6A 5W9, Canada.
Lagerwaard F; Department of Radiation Oncology, Amsterdam University Medical Centre, Amsterdam, 1081, The Netherlands.
Zindler J; Department of Radiation Oncology, Haaglanden Medical Centre, Den Hague, 2512VA, The Netherlands.; Holland Proton Centre, Delft, 2629JA, The Netherlands.
Hajdok G; Department of Medical Biophysics, Western University, London, N6A 3K7, Canada.
Ward AD; Department of Medical Biophysics, Western University, London, N6A 3K7, Canada.; Gerald C. Baines Centre, London Health Sciences Centre, London, N6A 5W9, Canada.; Department of Oncology, Western University, London, N6A 3K7, Canada.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 28; Vol. 13 (1), pp. 20977. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:
Journal Article
MeSH Terms:
Radiosurgery*/methods
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/radiotherapy
Brain Neoplasms*/secondary
Humans ; Magnetic Resonance Imaging/methods ; Machine Learning ; Observer Variation ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Noninvasive cardiac radioablation for ventricular tachycardia: dosimetric comparison between linear accelerator- and robotic CyberKnife-based radiosurgery systems.
Autorzy:
Wang CY; Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
Ho LT; Division of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan.
Lin LY; Division of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan.
Chan HM; Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
Chen HY; Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
Yu TL; Department of Radiation Oncology, Fu-Jen Catholic University Hospital, Taipei, Taiwan.
Huang YS; Department of Medical Imaging, National Taiwan University Hospital, No. 7, Chung-Shan S. Rd., Taipei, 100, Taiwan.; Department of Radiology, National Taiwan University College of Medicine, Taipei, Taiwan.
Kuo SH; Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Radiation Oncology, National Taiwan University Cancer Center, No. 57, Ln. 155, Sec. 3, Keelung Rd., Taipei, 106, Taiwan.
Lee WJ; Department of Medical Imaging, National Taiwan University Hospital, No. 7, Chung-Shan S. Rd., Taipei, 100, Taiwan. .; Department of Radiology, National Taiwan University College of Medicine, Taipei, Taiwan. .
Chen JL; Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. .; Department of Radiation Oncology, National Taiwan University Cancer Center, No. 57, Ln. 155, Sec. 3, Keelung Rd., Taipei, 106, Taiwan. .; Department of Radiology, National Taiwan University College of Medicine, Taipei, Taiwan. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2023 Nov 10; Vol. 18 (1), pp. 187. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Radiosurgery*
Robotic Surgical Procedures*
Radiotherapy, Intensity-Modulated*
Tachycardia, Ventricular*/radiotherapy
Tachycardia, Ventricular*/surgery
Humans ; Radiotherapy Planning, Computer-Assisted ; Particle Accelerators ; Radiotherapy Dosage
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.
Autorzy:
Roussot N; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France.; Cancer Biology Transfer Platform, Dijon, France.; University of Burgundy-Franche Comté, Dijon, France.; UMR INSERM 1231, Dijon, France.
Fumet JD; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France. .; Cancer Biology Transfer Platform, Dijon, France. .
Limagne E; Cancer Biology Transfer Platform, Dijon, France.; GIMI Genetic and Immunology Medical Institute, Dijon, France.; University of Burgundy-Franche Comté, Dijon, France.; UMR INSERM 1231, Dijon, France.
Thibaudin M; Cancer Biology Transfer Platform, Dijon, France.; GIMI Genetic and Immunology Medical Institute, Dijon, France.; UMR INSERM 1231, Dijon, France.
Hervieu A; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France.
Hennequin A; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France.
Zanetta S; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France.
Dalens L; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France.
Fourrier T; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France.
Galland L; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France.
Jacob P; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France.
Bertaut A; Department of Epidemiology and Biostatistics, Center GF Leclerc, Dijon, France.
Rederstorff E; Department of Epidemiology and Biostatistics, Center GF Leclerc, Dijon, France.
Chevalier C; Department of Radiotherapy, Center GF Leclerc, Dijon, France.
Ghirardi S; Department of Radiotherapy, Center GF Leclerc, Dijon, France.
Gilbert E; Department of Radiotherapy, Center GF Leclerc, Dijon, France.
Khoukaz A; Department of Radiotherapy, Center GF Leclerc, Dijon, France.
Martin E; Department of Radiotherapy, Center GF Leclerc, Dijon, France.
Nicolet C; Department of Radiotherapy, Center GF Leclerc, Dijon, France.
Quivrin M; Department of Radiotherapy, Center GF Leclerc, Dijon, France.
Thibouw D; Department of Radiotherapy, Center GF Leclerc, Dijon, France.
Vulquin N; Department of Radiotherapy, Center GF Leclerc, Dijon, France.
Truc G; Department of Radiotherapy, Center GF Leclerc, Dijon, France.
Rouffiac M; Department of Radiotherapy, Center GF Leclerc, Dijon, France.
Ghiringhelli F; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France.; Cancer Biology Transfer Platform, Dijon, France.; GIMI Genetic and Immunology Medical Institute, Dijon, France.; University of Burgundy-Franche Comté, Dijon, France.; UMR INSERM 1231, Dijon, France.
Mirjolet C; UMR INSERM 1231, Dijon, France.; Radiation Oncology Department, Preclinical Radiation Therapy and Radiobiology Unit, Center GF Leclerc, Unicancer, Dijon, France.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Nov 09; Vol. 23 (1), pp. 1080. Date of Electronic Publication: 2023 Nov 09.
Typ publikacji:
Clinical Trial, Phase I; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Renal Cell*/drug therapy
Radiosurgery*/adverse effects
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/drug therapy
Antineoplastic Agents*/therapeutic use
Kidney Neoplasms*/drug therapy
Head and Neck Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/drug therapy
Humans ; B7-H1 Antigen ; Antibodies, Monoclonal/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcoma.
Autorzy:
Somasundaram E; Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Anderson PM; Department of Pediatric Hematology Oncology and Blood and Marrow Transplantation, Cleveland Clinic, Cleveland, OH, USA.
Smile TD; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, R3 9500 Euclid Ave, Cleveland, 44195, OH, USA.
Halima A; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, R3 9500 Euclid Ave, Cleveland, 44195, OH, USA.
Broughman JB; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, R3 9500 Euclid Ave, Cleveland, 44195, OH, USA.
Reddy CA; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, R3 9500 Euclid Ave, Cleveland, 44195, OH, USA.
Parsai S; Department of Radiation Oncology, Ohio Health Riverside Methodist Hospital, Columbus, OH, USA.
Scott JG; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, R3 9500 Euclid Ave, Cleveland, 44195, OH, USA.
Chan T; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, R3 9500 Euclid Ave, Cleveland, 44195, OH, USA.
Campbell S; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, R3 9500 Euclid Ave, Cleveland, 44195, OH, USA.
Angelov L; Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, USA.
Zahler S; Department of Pediatric Hematology Oncology and Blood and Marrow Transplantation, Cleveland Clinic, Cleveland, OH, USA.
Trucco M; Department of Pediatric Hematology Oncology and Blood and Marrow Transplantation, Cleveland Clinic, Cleveland, OH, USA.
Thomas SM; Department of Pediatric Hematology Oncology and Blood and Marrow Transplantation, Cleveland Clinic, Cleveland, OH, USA.
Johnson S; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, R3 9500 Euclid Ave, Cleveland, 44195, OH, USA.
Qi P; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, R3 9500 Euclid Ave, Cleveland, 44195, OH, USA.
Magnelli A; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, R3 9500 Euclid Ave, Cleveland, 44195, OH, USA.
Murphy ES; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, R3 9500 Euclid Ave, Cleveland, 44195, OH, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 07; Vol. 13 (1), pp. 19256. Date of Electronic Publication: 2023 Nov 07.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Radiosurgery*
Sarcoma*/radiotherapy
Sarcoma*/surgery
Humans ; Treatment Outcome ; Neutrophils ; Retrospective Studies ; Lymphocytes ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Bevacizumab reduces peritumoral brain edema in lung cancer brain metastases after radiotherapy.
Autorzy:
Hua YC; Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Gao DZ; Department of Gamma Knife center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Wang KY; Department of Gamma Knife center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Ding XS; Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Xu WR; Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Li YB; Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Shi WW; Department of Oncology, PLA General Hospital, Beijing, China.
Sun SB; Department of Gamma Knife center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Li XY; Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Nov; Vol. 14 (31), pp. 3133-3139. Date of Electronic Publication: 2023 Sep 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lung Neoplasms*/drug therapy
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/etiology
Brain Edema*/drug therapy
Brain Edema*/etiology
Brain Edema*/pathology
Radiosurgery*/methods
Brain Neoplasms*/drug therapy
Brain Neoplasms*/radiotherapy
Brain Neoplasms*/secondary
Humans ; Bevacizumab/pharmacology ; Bevacizumab/therapeutic use ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Outcome of conventional radiotherapy in small centrally located tumours or lymph nodes: minimal toxicity, remarkable survival but challenging loco-regional control.
Autorzy:
Knap MM; Department of Oncology, Aarhus University Hospital, Aarhus N, Denmark.
Khan S; Department of Respiratory Diseases and Allergology, Aarhus University Hospital, Aarhus N, Denmark.
Khalil AA; Department of Oncology, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark.
Møller DS; Department of Oncology, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark.
Hoffmann L; Department of Oncology, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Nov; Vol. 62 (11), pp. 1433-1439. Date of Electronic Publication: 2023 Sep 14.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*
Lung Neoplasms*/pathology
Radiosurgery*/methods
Humans ; Retrospective Studies ; Disease-Free Survival ; Lymph Nodes/pathology ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical Outcome of Stereotactic Body Radiotherapy in Patients with Early-Stage Lung Cancer with Ground-Glass Opacity Predominant Lesions: A Single Institution Experience.
Autorzy:
Jang JY; Departments of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Kim SS; Departments of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Song SY; Departments of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Shin YS; Departments of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Lee SW; Departments of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Ji W; Departments of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Choi CM; Departments of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Choi EK; Departments of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2023 Oct; Vol. 55 (4), pp. 1181-1189. Date of Electronic Publication: 2023 Mar 21.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/pathology
Radiosurgery*/adverse effects
Radiosurgery*/methods
Lung Neoplasms*/pathology
Humans ; Retrospective Studies ; Lung/pathology ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 21-40 z 27727

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies